Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.

Barkoff AM, Gröndahl-Yli-Hannuksela K, Vuononvirta J, Mertsola J, Kallonen T, He Q.

Vaccine. 2012 Nov 6;30(48):6897-902. doi: 10.1016/j.vaccine.2012.09.003. Epub 2012 Sep 13.

PMID:
22981763
2.

Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.

Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B.

Vaccine. 2013 Oct 25;31(45):5178-91. doi: 10.1016/j.vaccine.2013.08.034. Epub 2013 Aug 28. Review.

3.

Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.

Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB.

Pediatrics. 2001 Dec;108(6):E115. Review.

PMID:
11731642
4.

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.

Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH; EU Pertstrain group..

Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):307-12. doi: 10.1007/s10096-010-1104-y. Epub 2010 Nov 11. Review.

5.

Rationale for pertussis booster vaccination throughout life in Europe.

Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P.

Lancet Infect Dis. 2011 Jul;11(7):557-70. doi: 10.1016/S1473-3099(11)70007-X. Epub 2011 May 18. Review.

PMID:
21600850
6.

Pertussis of adults and infants.

von König CH, Halperin S, Riffelmann M, Guiso N.

Lancet Infect Dis. 2002 Dec;2(12):744-50. Review.

PMID:
12467690
7.

Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization.

van den Biggelaar AH, Poolman JT.

Expert Rev Vaccines. 2016;15(1):69-80. doi: 10.1586/14760584.2016.1105136. Epub 2015 Nov 11. Review.

PMID:
26559122
8.

Pertussis vaccination for health care workers.

Sandora TJ, Gidengil CA, Lee GM.

Clin Microbiol Rev. 2008 Jul;21(3):426-34. doi: 10.1128/CMR.00003-08. Review.

9.

Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults.

Nitsch-Osuch A, Korzeniewski K, Kuchar E, Zielonka T, Życińska K, Wardyn K.

Respir Physiol Neurobiol. 2013 Jun 1;187(1):99-103. doi: 10.1016/j.resp.2013.02.007. Epub 2013 Feb 16. Review.

PMID:
23419520
10.

Review of the laboratory approaches to the detection of antibody and cell-mediated immunity to pertussis disease and vaccine.

Edwards KM.

Expert Rev Vaccines. 2014 Oct;13(10):1183-90. doi: 10.1586/14760584.2014.946015. Epub 2014 Aug 6. Review.

PMID:
25096058
11.

Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.

Sheridan SL, Frith K, Snelling TL, Grimwood K, McIntyre PB, Lambert SB.

Expert Rev Vaccines. 2014 Sep;13(9):1081-106. doi: 10.1586/14760584.2014.944167. Epub 2014 Aug 5. Review.

PMID:
25093268
12.

Acellular pertussis vaccines in China.

Wang L, Lei D, Zhang S.

Vaccine. 2012 Nov 26;30(50):7174-8. doi: 10.1016/j.vaccine.2012.10.009. Epub 2012 Oct 19. Review.

PMID:
23084855
13.

T-cell immune responses to Bordetella pertussis infection and vaccination.

Fedele G, Cassone A, Ausiello CM.

Pathog Dis. 2015 Oct;73(7). pii: ftv051. doi: 10.1093/femspd/ftv051. Epub 2015 Aug 4. Review.

PMID:
26242279
14.

Pertussis vaccines and the challenge of inducing durable immunity.

Warfel JM, Edwards KM.

Curr Opin Immunol. 2015 Aug;35:48-54. doi: 10.1016/j.coi.2015.05.008. Epub 2015 Jun 17. Review.

PMID:
26091979
15.

Pertussis diagnostics: overview and impact of immunization.

Wirsing von König CH.

Expert Rev Vaccines. 2014 Oct;13(10):1167-74. doi: 10.1586/14760584.2014.950237. Epub 2014 Aug 21. Review.

PMID:
25142439
16.

Seroprevalence studies of pertussis: what have we learned from different immunized populations.

Barkoff AM, Gröndahl-Yli-Hannuksela K, He Q.

Pathog Dis. 2015 Oct;73(7). pii: ftv050. doi: 10.1093/femspd/ftv050. Epub 2015 Jul 24. Review.

PMID:
26208655
17.

[Whooping cough today].

Grimprel E.

Presse Med. 1999 Oct 9;28(30):1671-5. Review. French.

PMID:
10544703
18.

Immune persistence after pertussis vaccination.

Chen Z, He Q.

Hum Vaccin Immunother. 2017 Apr 3;13(4):744-756. doi: 10.1080/21645515.2016.1259780. Epub 2017 Jan 3. Review.

PMID:
28045580
19.

Pertussis in Portugal - time for a new strategy.

Gama de Sousa S, Barros H.

Rev Port Pneumol. 2010 Jul-Aug;16(4):573-88. Review. English, Portuguese.

PMID:
20700556
20.

Toward a mechanism-based in vitro safety test for pertussis toxin.

Vaessen SF, Bruysters MW, Vandebriel RJ, Verkoeijen S, Bos R, Krul CA, Akkermans AM.

Hum Vaccin Immunother. 2014;10(5):1391-5. doi: 10.4161/hv.28001. Epub 2014 Feb 19. Review.

Supplemental Content

Support Center